VINE SURGERY PARTNERSHIP
VINE SURGERY, HINDHAYES LANE, STREETHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 8 | 10 | 80.0% | |
HF 4 | 2011 | 12 | 13 | 92.3% | |
HF 4 | 2012 | 17 | 19 | 89.5% | |
HF 4 | 2013 | 16 | 17 | 94.1% | |
HF004 | 2014 | 14 | 16 | 87.5% | |
HF004 | 2015 | 17 | 20 | 85.0% | |
HF004 | 2016 | 16 | 18 | 88.9% | |
HF004 | 2017 | 16 | 17 | 94.1% | |
HF004 | 2018 | 39 | 45 | 86.7% | |
HF004 | 2019 | 60 | 65 | 92.3% | |
HF004 | 2020 | 54 | 63 | 85.7% | |
HF006 | 2021 | 60 | 61 | 98.4% | |
HF006 | 2022 | 62 | 63 | 98.4% | |
HF006 | 2023 | 105 | 109 | 96.3% |